Does CYTARABINE Cause Diffuse large b-cell lymphoma recurrent? 406 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 406 reports of Diffuse large b-cell lymphoma recurrent have been filed in association with CYTARABINE (cytarabine). This represents 0.9% of all adverse event reports for CYTARABINE.
406
Reports of Diffuse large b-cell lymphoma recurrent with CYTARABINE
0.9%
of all CYTARABINE reports
104
Deaths
67
Hospitalizations
How Dangerous Is Diffuse large b-cell lymphoma recurrent From CYTARABINE?
Of the 406 reports, 104 (25.6%) resulted in death, 67 (16.5%) required hospitalization, and 20 (4.9%) were considered life-threatening.
Is Diffuse large b-cell lymphoma recurrent Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for CYTARABINE. However, 406 reports have been filed with the FAERS database.
What Other Side Effects Does CYTARABINE Cause?
Febrile neutropenia (6,142)
Off label use (4,183)
Pyrexia (2,992)
Neutropenia (2,558)
Disease progression (2,352)
Drug ineffective (2,281)
Thrombocytopenia (2,148)
Sepsis (2,013)
Myelosuppression (1,869)
Product use in unapproved indication (1,619)
What Other Drugs Cause Diffuse large b-cell lymphoma recurrent?
RITUXIMAB (1,359)
CYCLOPHOSPHAMIDE (1,007)
VINCRISTINE (957)
DOXORUBICIN (953)
PREDNISONE (738)
DEXAMETHASONE (402)
ETOPOSIDE (375)
CISPLATIN (306)
GEMCITABINE (280)
BENDAMUSTINE (255)
Which CYTARABINE Alternatives Have Lower Diffuse large b-cell lymphoma recurrent Risk?
CYTARABINE vs CYTARABINE\DAUNORUBICIN
CYTARABINE vs DABIGATRAN
CYTARABINE vs DABIGATRAN ETEXILATE
CYTARABINE vs DABRAFENIB
CYTARABINE vs DABRAFENIB\TRAMETINIB